Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Recently published research from the University of Minnesota Medical School suggests individuals with hepatitis C should consider revaccination for hepatitis B. The study was published in the Journal of Infectious Diseases.

AbbVie and Incyte report PhIIb vitiligo data on oral JAKs analysts call ‘undifferentiated’

AbbVie and Incyte presented positive Phase IIb results of their respective oral JAK inhibitors in non-segmental vitiligo (NSV) at the European Academy of Dermatology and

October 13, 2023

Dementia risk may increase with long-term use of acid reflux drugs

People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people

August 10, 2023

NIH will bring clinical research into primary care offices with $30 million pilot

For many Americans, health care means going to a local primary care office. But the vast majority of clinical research is conducted inside the walls

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.